Bristol-Myers’s Reliance on Three Drugs Casts Doubt on Strategy
Wednesday, January 28, 2009 - 00:42
in Psychology & Sociology
Bristol-Myers Squibb’s current strategy is to move away from mass-market drugs into more expensive drugs for rarer diseases. But more than half its sales depend on three drugs alone.